These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2964326)

  • 41. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene).
    Clocquet AR; Egan JM; Stoffers DA; Muller DC; Wideman L; Chin GA; Clarke WL; Hanks JB; Habener JF; Elahi D
    Diabetes; 2000 Nov; 49(11):1856-64. PubMed ID: 11078452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy.
    Hosker JP; Rudenski AS; Burnett MA; Matthews DR; Turner RC
    Metabolism; 1989 Aug; 38(8):767-72. PubMed ID: 2668699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?
    Gungor N; Bacha F; Saad R; Janosky J; Arslanian S
    Diabetes Care; 2005 Mar; 28(3):638-44. PubMed ID: 15735201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes.
    Mills GW; Avery PJ; McCarthy MI; Hattersley AT; Levy JC; Hitman GA; Sampson M; Walker M
    Diabetologia; 2004 Apr; 47(4):732-8. PubMed ID: 15298351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.
    Li Y; Xu W; Liao Z; Yao B; Chen X; Huang Z; Hu G; Weng J
    Diabetes Care; 2004 Nov; 27(11):2597-602. PubMed ID: 15504992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pancreatic beta-cell function and insulin sensitivity in japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus.
    Kanauchi M; Nakajima M; Saito Y; Kanauchi K
    Metabolism; 2003 Apr; 52(4):476-81. PubMed ID: 12701062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes.
    Thamer C; Haap M; Heller E; Joel L; Braun S; Tschritter O; Haring H; Fritsche A
    Horm Metab Res; 2006 Mar; 38(3):178-82. PubMed ID: 16673209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
    Maggs DG; Buchanan TA; Burant CF; Cline G; Gumbiner B; Hsueh WA; Inzucchi S; Kelley D; Nolan J; Olefsky JM; Polonsky KS; Silver D; Valiquett TR; Shulman GI
    Ann Intern Med; 1998 Feb; 128(3):176-85. PubMed ID: 9454525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
    Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
    Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes.
    Lin JM; Fabregat ME; Gomis R; Bergsten P
    Diabetes; 2002 Apr; 51(4):988-93. PubMed ID: 11916916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects.
    Cook JT; Levy JC; Page RC; Shaw JA; Hattersley AT; Turner RC
    BMJ; 1993 Jan; 306(6873):302-6. PubMed ID: 8461648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beneficial effect of long-term combined treatment with voglibose and pioglitazone on pancreatic islet function of genetically diabetic GK rats.
    Ishida H; Kato S; Nishimura M; Mizuno N; Fujimoto S; Mukai E; Kajikawa M; Yamada Y; Odaka H; Ikeda H; Seino Y
    Horm Metab Res; 1998 Nov; 30(11):673-8. PubMed ID: 9918384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The key role of islet dysfunction in type II diabetes mellitus.
    Porte D; Kahn SE
    Clin Invest Med; 1995 Aug; 18(4):247-54. PubMed ID: 8549009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The classification and prognostic implication of islet β cell function before and in remission period in newly diagnosed diabetic patients with ketosis].
    Fan H; Zhang PR; Liu J; Xu Y
    Zhonghua Nei Ke Za Zhi; 2012 Feb; 51(2):108-13. PubMed ID: 22490810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rosiglitazone monotherapy is effective in patients with type 2 diabetes.
    Lebovitz HE; Dole JF; Patwardhan R; Rappaport EB; Freed MI;
    J Clin Endocrinol Metab; 2001 Jan; 86(1):280-8. PubMed ID: 11232013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.